Fady Boctor
President chez PETROS PHARMACEUTICALS
Fortune : 73 475 $ au 31/03/2024
Profil
Fady Boctor is currently the Chief Commercial Officer at Metuchen Pharmaceuticals LLC and the President & Chief Commercial Officer at Petros Pharmaceuticals, Inc. He previously worked as the Marketing Director at Emergent Devices, Inc. from 2017 to 2019 and as the Marketing Manager at Endo International Plc from 2010 to 2017.
Mr. Boctor holds an undergraduate degree from Hamline University and an MBA from Alliance Manchester Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/03/2024 | 49 645 ( 2,26% ) | 73 475 $ | 31/03/2024 |
Postes actifs de Fady Boctor
| Sociétés | Poste | Début |
|---|---|---|
| PETROS PHARMACEUTICALS | President | 01/12/2020 |
Metuchen Pharmaceuticals LLC
 Metuchen Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Metuchen Pharmaceuticals LLC operates as a pharmaceuticals company. It develops, markets, sells and distributes Stendra drug. The company was foundeded in 2016 and is headquartered in Cranford, NJ. | Corporate Officer/Principal | - |
Anciens postes connus de Fady Boctor
| Sociétés | Poste | Fin |
|---|---|---|
Emergent Devices, Inc.
 Emergent Devices, Inc. Pharmaceuticals: MajorHealth Technology Part of Emergent BioSolutions, Inc., Emergent Devices, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Plymouth Meeting, PA. | Sales & Marketing | 01/03/2019 |
| ENDO INTERNATIONAL PLC | Sales & Marketing | 01/05/2017 |
Formation de Fady Boctor
| Hamline University | Undergraduate Degree |
| Alliance Manchester Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PETROS PHARMACEUTICALS | Health Technology |
| Entreprise privées | 3 |
|---|---|
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Metuchen Pharmaceuticals LLC
Metuchen Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Metuchen Pharmaceuticals LLC operates as a pharmaceuticals company. It develops, markets, sells and distributes Stendra drug. The company was foundeded in 2016 and is headquartered in Cranford, NJ. | Health Technology |
Emergent Devices, Inc.
Emergent Devices, Inc. Pharmaceuticals: MajorHealth Technology Part of Emergent BioSolutions, Inc., Emergent Devices, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Plymouth Meeting, PA. | Health Technology |
